Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05117008 |
|---|---|
| Brief Title: | Maintenance Belantamab Mafodotin (Blenrep®) After B-cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed and/or Refractory Multiple Myeloma (EMBRACE) |
| First Submitted : | November 2, 2021 |
| First Submitted that Met QC Criteria : | November 2, 2021 |
| First Posted : | November 11, 2021 |
| Last Update Submitted that Met QC Criteria : | August 3, 2022 |
| Last Update Posted : | August 4, 2022 |